Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Accumulated Expenses (2022 - 2023)

Bluejay Diagnostics (BJDX) has disclosed Accumulated Expenses for 2 consecutive years, with $1.4 million as the latest value for Q2 2023.

  • Quarterly Accumulated Expenses rose 77.72% to $1.4 million in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Jun 2023, up 77.72% year-over-year, with the annual reading at $835730.0 for FY2022, N/A changed from the prior year.
  • Accumulated Expenses hit $1.4 million in Q2 2023 for Bluejay Diagnostics, up from $863397.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $1.4 million in Q2 2023 to a low of $592622.0 in Q1 2022.